drugset / Trial / NCT00617747
Efficacy and Tolerability of Zolmitriptan Nasal Spray
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the effectiveness and tolerability (the ability not to experience ill effects from the study drug) of a zolmitriptan nasal spray, 5.0 mg, compared with placebo (inactive drug) for 2 migraine headaches for up to 12 weeks in adult subjects with migraine headaches
Timeline
- Start
- 2002-09
- Primary completion
- —
- Completion
- 2003-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zolmitriptan | Small molecule | 5 mg | Intranasal |